U.S. markets close in 1 hour 58 minutes
  • S&P 500

    3,847.19
    -23.10 (-0.60%)
     
  • Dow 30

    31,472.99
    +81.47 (+0.26%)
     
  • Nasdaq

    13,095.01
    -263.78 (-1.97%)
     
  • Russell 2000

    2,239.12
    +7.61 (+0.34%)
     
  • Crude Oil

    61.64
    +1.89 (+3.16%)
     
  • Gold

    1,718.50
    -15.10 (-0.87%)
     
  • Silver

    26.41
    -0.47 (-1.76%)
     
  • EUR/USD

    1.2076
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.4720
    +0.0570 (+4.03%)
     
  • GBP/USD

    1.3971
    +0.0015 (+0.10%)
     
  • USD/JPY

    106.9450
    +0.2350 (+0.22%)
     
  • BTC-USD

    51,235.84
    +3,295.61 (+6.87%)
     
  • CMC Crypto 200

    1,025.98
    +37.88 (+3.83%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Marathon Patent Group (NASDAQ:MARA) Share Prices Have Dropped 88% In The Last Five Years

  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

Marathon Patent Group, Inc. (NASDAQ:MARA) shareholders should be happy to see the share price up 29% in the last month. But will that repair the damage for the weary investors who have owned this stock as it declined over half a decade? Probably not. Five years have seen the share price descend precipitously, down a full 88%. So we don't gain too much confidence from the recent recovery. The real question is whether the business can leave its past behind and improve itself over the years ahead.

We really feel for shareholders in this scenario. It's a good reminder of the importance of diversification, and it's worth keeping in mind there's more to life than money, anyway.

View our latest analysis for Marathon Patent Group

Because Marathon Patent Group made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally expect to see good revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

Over half a decade Marathon Patent Group reduced its trailing twelve month revenue by 56% for each year. That puts it in an unattractive cohort, to put it mildly. So it's not that strange that the share price dropped 14% per year in that period. We don't think this is a particularly promising picture. Of course, the poor performance could mean the market has been too severe selling down. That can happen.

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

earnings-and-revenue-growth
earnings-and-revenue-growth

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

A Different Perspective

We're pleased to report that Marathon Patent Group shareholders have received a total shareholder return of 88% over one year. Notably the five-year annualised TSR loss of 14% per year compares very unfavourably with the recent share price performance. We generally put more weight on the long term performance over the short term, but the recent improvement could hint at a (positive) inflection point within the business. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 4 warning signs for Marathon Patent Group (1 is potentially serious!) that you should be aware of before investing here.

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.